Background: Earlier meta-analyses of small randomized trials suggested that mechanical bowel preparation (MBP) should be omitted before colorectal surgery because it does not affect complication rates 0 mortality and may be even harmful; however, more recent large randomized trials suggested an increased occurrence of pelvic abscesses in the absence of MBP. Therefore, an updated large meta-analysis was conducted to re-evaluate the role of MBP in colorectal surgery. Furthermore, the influence of different kind of MBP regimes on infectious outcomes was examined. Methods: The meta-analysis was conducted according to the QUOROM statement; the inclusion criteria were randomized clinical trials comparing MBP with no MBP before colorectal surgery. The primary outcome was anastomotic leakage; secondary outcomes were other septic complications. Results: Fourteen trials were included with a total number of 4859 patients: 2452 in the MBP group and 2407 in the no MBP group. We found no statistical difference between the groups for anastomotic leakage ͓OR ϭ 1.12 (0.82-1.53), P ϭ 0.46͔, pelvic or abdominal abscess (P ϭ 0.75), and wound sepsis (P ϭ 0.11). When all surgical site infections were considered, the meta-analysis favored no MBP ͓OR ϭ 1.40 (1.05-1.87), P ϭ 0.02͔.
U ntil recently, preparation and cleansing of the bowel before colorectal surgery was a major surgical dogma, even if over 30 years ago a randomized clinical trial (RCT) questioned this dogma, suggesting that vigorous mechanical bowel preparation (MBP) was unnecessary. 1 Furthermore, several small randomized clinical trials have been published to assess the omission of MBP. During the last decade, 4 meta-analyses [2] [3] [4] [5] of RCT comparing MBP with no MBP, have also been published. They concluded that MBP should be abandoned before colon surgery since it could be associated with a higher risk of anastomotic leakage. But all these reviews (including our own meta-analysis 3 ) included small RCTs. More recently, 2 large scale RCTs have become available and reported similar risk of anastomotic leakage but suggested slightly more deep abdominal abscesses in the absence of MBP. 6, 7 The greater the number of patients in a meta-analysis, the greater is its power to detect a possible treatment effect, and so it appears appropriate to perform a further analysis taking into account all the information currently available. The present systematic review is an update of our previously published meta-analysis 3 aiming to answer the question in the light of most recent published data.
METHODS

Searching, Selection of Trials, and Data Abstraction
This is a systematic review and meta-analysis of both published and unpublished data conducted according to the QUOROM statement 8 and updating our former meta-analysis. 3 All the items of the QUOROM checklist were satisfied including the structured abstract, introduction (rational for review), methods (searching, selection of trials, validity assessment, data abstraction, study characteristics and quantitative data synthesis), results (trial flow, study characteristics, quantitative data synthesis), and discussion (summary of key findings, discussion of internal and external validity).
The search, according to the same strategy used previously, was performed in January 2008. Briefly, the search combined 3 sources: electronic databases (Cochrane Library, Medline, and Scopus), manual search of the last 6 issues of major surgical journals (and of the proceedings of major meetings from 2004), and the references lists of published articles.
Two independent reviewers selected the trials to be included by reading the abstracts. Only studies designed as randomized clinical trials comparing MBP with no MBP before elective colorectal surgery were included. Dual publications were considered once by including the most relevant or the latest article.
Validity Assessment of Trials
The methodological quality of the included trials was assessed by means of a validated scale 9 by 2 independent reviewers; and the final score was established by consensus. Since the patients do know their regimen, double-blinding was not feasible and singleblinding was considered appropriate. According to Moher et al, 9 the methodological quality of a trial is considered poor when the score is 2 or less. Data were collected independently by the 2 reviewers and cross-checked. For the purpose of the present update, the authors of RCTs have been further contacted to obtain unpublished data regarding subgroups for the sensitivity analysis.
Collection of Data
The following data were collected for each trial: type of randomization, sample size, blinding, withdrawals and dropout, type of bowel preparation (oral vs. enema), the solution used ͓polyethylene glycol (PEG), mannitol, sodium phosphates͔, type of colonic or rectal procedure, or level of the anastomosis (peritoneal vs. infraperitoneal), surgical site infections (SSI) including organ/space infections (anastomotic leakages, pelvic or abdominal abscesses, or peritonitis), and wound infections. Confounding factors, such as intraoperative peritoneal contamination (spillage of liquid bowel content), surgical technique (stapled or handsewn anastomosis), and abdominal drainage, were also recorded.
Outcome Measurements and Sensitivity Analysis
Data were collected independently by 2 reviewers and crosschecked. Outcomes were analyzed on an intention-to-treat basis. The primary outcome was anastomotic leakage. Secondary outcomes were other infectious complications (pelvic abscess, peritonitis, wound infection), overall SSI, reoperations, extra-abdominal infectious complications (bronchopulmonary complications, urinary tract infection), hospital stay duration, and deaths.
Sensitivity analysis assessing the robustness of the results included heterogeneity analysis and subgroups analyses (poor-quality vs. good-quality trials, large vs. small RCTs, PEG vs. other solutions, peritoneal vs. infraperitoneal anastomosis).
Statistical Analysis
Overall estimates of treatment effect and their 95% confidence intervals were calculated using Peto method for random effects (odds ratio; OR). The Q estimator was calculated to test heterogeneity between studies. Where possible, the impact of a moderator variable was assessed by mixed effects analysis of variance. All calculations were made using comprehensive meta-analysis software from Biostat Inc. (Engelwood, NJ). Figure 1 summarizes the trials flow. Eventually, 14 trials were included in the meta-analysis 6,7,10 -22 containing a total of 4859 patients: 2452 who had MBP and 2407 who had no MBP. One trial was published twice 15, 16 but has been considered only once. The characteristics of included trials are summarized in Table 1 . Calculation of sample size has been reported in 5 trials, on the basis of wound infection, 19, 22 anastomotic leakage, 7 or postoperative morbidity rates. 6, 20 Regarding the data for subgroup analyses according to the solutions used when 2 solutions of MBP were reported, 6,7,17 2 authors 6,7 did provide unpublished data but one author was not able to provide data related to each solution used. 17 Regarding the data related to the level of the anastomosis, the authors of the earlier trial 10 responded that the data were no longer available; 1 author 18 did provide unpublished data, whereas the others did not respond or were not able to provide us further details.
RESULTS
Characteristics of Trials
All but 2 studies 10, 17 reported that, the groups were well matched for age, sex, diagnosis, and type of procedure. All trials enrolled patients older than 18 years who underwent elective colorectal surgery; 1 trial 12 also included children and 2 12, 15, 16 included patients without anastomosis. All trials except 3 stipulated "no additional bowel or rectal cleansing" in the no MBP group; in 3 trials, 6, 18, 20 patients undergoing rectal surgery were given an enema on the day of operation. In all trials, confirmation of anastomotic leakage was obtained only when a leak was suspected clinically; no trial reported routine radiographic examination. The funnel plot (Fig. 2 ) for the primary outcome (anastomotic leakage) was symmetric.
Overall Meta-Analysis
Overall analyses showed that there was no statistically significant difference whether the patients underwent or not MBP concerning the primary outcome ie, anastomotic leakage ͓4.02% after MBP vs. 3.44%, OR ϭ 1.12 (95% CI ϭ 0.82-1.53; P ϭ 0.46); Fig. 3͔ , there was also no significant difference for the other outcomes ( Table 2) , particularly for pelvic or abdominal abscess (Fig. 4 ). The only significant difference concerned the outcome "all SSI" and favored the absence of MBP ͓15.7% after MBP vs. 14.58, OR ϭ 1.40 (95% CI ϭ 1.05-1.87; P ϭ 0.02); Fig. 5͔ . 
Sensitivity Analyses
PEG and Sodium Phosphates Results
Nine trials 6,7,10,13,14,18 -20,22 for PEG 4 6, 7, 11, 21 for sodium phosphate were considered, the data of 2 trials 6,7 were unpublished and were included as supplied by the authors of the RCTs. There were no statistical differences between the groups for all the outcomes considered ( Table 3 ).
Quality of Trials and Large Versus Small Trials
Eliminating 3 trials 10,17,21 with suboptimal quality did not change the results except for abdominal abscesses with a significant There was no heterogeneity. To note: the more the trial is small, the more the confidence interval is large. To note: the relative weight of the most recent trials. 6, 7 there were no differences for all parameters except for abdominal abscesses with a significant effect in favor of MBP, OR ϭ 0.46 (0.27-0.78), P ϭ 0.004. Table 4 details the differences between small and large trials for infectious outcomes and death.
Rectal Surgery
In the majority of trials, rectal surgery was considered as a noninclusion criterion or could not be analyzed separately. Six trials 11, 12, 14, 18, 20, 21 involved a stratification for infra-peritoneal OR Ͻ1 favors MBP, p tests the difference between large and small trials. There were significant differences between large and small trials for all outcomes except for wound infection and death. In small trials, the findings favored no MBP for the majority of outcomes. In large trials the differences were not significantly different except for abdominal abscesses favoring no MBP.
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Review of Randomized Clinical Trials anastomosis or reported some results after rectal surgery in a limited number of patients (215 with MBP vs. 204 without MBP). In addition to this lower number, the variety of the solutions used (sodium phosphates, 11,21 mannitol, 12 PEG 14, 18, 20 ) precludes the performance of a formal meta-analysis.
DISCUSSION
The present updated meta-analysis represents the largest systematic review providing clearly the best available evidence on the role of MBP in colon surgery. The main finding is that, in contrast with all previously published meta-analyses 2-5 of small trials that suggested a higher risk of anastomotic leakage after MBP, the detrimental effect of MBP is not demonstrated in the present update. The weight of 2 recent trials from Sweden 6 and the Netherlands 7 (Figs. 3-5) seems important in these findings and participated to reduce the effect size.
Sensitivity analysis suggests that published small RCTs (and subsequently their meta-analyses) probably overestimated the effect size of anastomotic leakage after MBP which was not confirmed in the large trials 6, 7 and in this meta-analysis. Despite the symmetrical presentation of the funnel plot we cannot exclude a publication bias, small trials showing no difference being unlikely to be published because of a presumed lack of power. Furthermore, discrepancies between meta-analyses of small trials and large trials (or their meta-analyses) have been discussed elsewhere. 23 Large randomized trials and their meta-analyses provide a better source of evidence than meta-analyses of small trials.
Again, these 2 large trials have also influenced the results in the subgroup analyses with a 2-fold higher risk of deep pelvic or abdominal abscesses in patients who did not undergo MBP before surgery. Although this effect was statistically significant, it is in our opinion not clinically relevant or even prohibitive since the number need to harm is very high (n ϭ 333 patients).
Another important finding concerns the type of MBP. Previous meta-analyses have evaluated mainly PEG regimen, and our own previous meta-analysis 3 suggested that increased risk of anastomotic leakages was related to PEG and failed to show significant results for sodium phosphates because of the small number of patients included in the only RCT 11 using sodium phosphates. 3 Some authors advocated the use of sodium phosphates instead of PEG since the former are "equally effective" and well tolerated by patients. 24 This update is the first to answer the question by showing similar results after both PEG and sodium phosphates MBP in a large number of patients (Table 3) . Consequently, PEG and sodium phosphates should be considered similarly.
Other aspects of colorectal surgery deserve comments. In almost all RCTs, small lesions (less than 2 cm) were excluded. Thus the finding of the present meta-analysis cannot be extrapolated to such lesions, all the more as they can require an intraoperative (endoscopic or manual) localization. One can advice to selectively perform MBP in these patients.
All included RCTs concerned open surgery and the extrapolation of the results to laparoscopic colorectal surgery could be inappropriate for the purists. Few studies have assessed MBP in this setting. 25, 26 These uncontrolled studies showed that with adequate selection criteria (lesions greater than 3 cm) laparoscopic colorectal surgery can be safely performed. Furthermore, in our opinion, in comparison with its conventional counterpart, laparoscopic surgery is "only" a different access to the abdominal cavity with less postoperative infectious morbidity. 27 We consider, despite the absence of strong evidence, the conclusions of the present metaanalysis to be extrapolated to laparoscopic colon surgery. Furthermore, owing to the body of evidence against routine MBP it is, in our opinion unlikely that a large RCT comparing MBP with no MBP before laparoscopic colon surgery would ever be published.
Beside the role of MBP before colonic surgery, its role in rectal surgery especially in low colorectal or coloanal anastomoses could not be assessed in the present meta-analysis where most trials did not include such patients. There in not enough data allowing a conclusion in the field of rectal surgery. The results of the ongoing trial addressing this topic in France (ClinicalTrials. gov Identifier # NCT00554892) are awaited.
Quality of life of patients should also be considered. It is obvious that no MBP is more convenient and more comfortable to patients. Jung et al showed in a RCT 28 that patients prefer not to have MBP and are less willing to have the same procedure again. Furthermore, MBP has been also shown to be associated with other drawbacks such as bacterial translocation, 13 electrolyte disturbance mainly in mildly dehydrated or elderly patients. 29, 30 In conclusion, the present updated meta-analysis confirms that MBP does not reduce the risk of infectious morbidity after colon surgery, but it undermines the potential detrimental or harmful effect of MBP in terms of anastomotic leakages. The increased risk of intra-abdominal abscesses in the absence of MBP does not seem to be clinically relevant. MBP should be abandoned at least from the patients' perspective. The main limitation of this meta-analysis concerns the role of MBP in rectal surgery (with low anastomoses), which remains to be evaluated.
